Dako Exhibitor Seminar
Improving Patient Safety by pharmDx™-TOP2A a New Marker
Tuesday, March 10, 2009
5:30 pm to 7:30 pm
Room 206 - Hynes Convention Center
CRi Exhibitor Seminar
Paving the New "Path": Advancing Pathology Using Multi-Molecular Imaging for Tissue-Based Quantitation
Monday, March 9, 2009
5:30 pm to 7:30 pm
Room 202 - Hynes Convention Center
MTM Laboratories, Inc. Exhibitor Seminar
Biomarkers for Cervical Cancer Screening and Diagnosis
Tuesday, March 10, 2009
7:00 am to 8:00 am
Room 206-Hynes Convention Center
Biocare Medical Exhibitor Seminar
Optimization of Diagnostic and Prognostic Outcomes with Chromogenic ISH and Novel Multiplex Biomarker Stains
Introducing novel multiplex biomarker stains and chromogenic in situ hybridization (ISH) technologies for optimized diagnostic and prognostic evaluation of (i) accurate determination of benign proliferative, noninvasive vs. invasive breast cancers; (ii) evaluation ADH, breast hyperplasia, microinvasion, vs. basal phenotypes; (iii) differentiation of urothelial carcinoma in situ (CIS) from reactive atypia of the urothelium and (iv) rapid assessment of HER2 gene amplification status for Herceptin® treatment.
Monday, March 9, 2009
5:30 pm to 7:30 pm
Room 206-Hynes Convention Center
Genomic Health Exhibitor Seminar
Integrating Oncotype DX® Results with Standard Pathology Practice in Breast Cancer
Tuesday, March 10, 2009
7:00 am to 8:00 am
Room 202-Hynes Convention Center
BioImagene Exhibitor Seminar
Enabling Personalized Medicine Through Innovative Digital Pathology
Sunday, March 8, 2009
5:30 pm to 7:30 pm
Room 206-Hynes Convention Center
